← ALTERITY THERAPEUTICS LTD
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | — | $132k |
$201k
+51.95%
|
$109k
-46.05%
|
$17k
-84.23%
|
$21k
+20.79%
|
$3k
-87.89%
|
$16k
+556.39%
|
$268k
+1533.12%
|
$446k
+66.27%
|
$0
-100.00%
|
|
| Research and development | — | $5.7m | $6.7m | $13.0m | $10.1m | $12.3m | $14.7m | $13.2m | $18.6m | $14.4m | $14.4m | |
| General and administrative | — | — | $4.3m | $4.3m | $3.4m | $6.9m | $5.5m | $5.1m | $4.8m | $5.5m | $5.3m | |
| Operating expenses: | ||||||||||||
| Other operating expenses | — | ($126k) | ($58k) | ($133k) | ($44k) | ($2k) | ($1k) | ($29k) | ($5k) | ($87k) | — | |
| Interest Expense | — | — | — | — | $4k | $1k | $2k | $5k | $7k | $6k | — | |
| Interest income | — | $132k | $201k | $109k | $17k | $21k | $3k | $16k | $268k | $446k | $446k | |
| Other Income | — | $3.0m | $3.1m | $5.0m | $123k | $4.5m | $5.1m | $3.9m | $4.0m | $7.6m | — | |
| Current Tax Expense (Income) | — | — | $0 | $0 | — | — | $50k | $34k | $58k | $77k | — | |
| Deferred Tax Expense (Income) | — | — | $0 | $0 | — | — | — | — | — | — | — | |
| Income Tax Expense Continuing Operations | — | $0 | $0 | $0 | — | — | $70k | $104k | $46k | $68k | $68k | |
| Loss before income tax expense | — | ($7.5m) | ($8.3m) | ($12.3m) | ($13.5m) | ($15.3m) | ($12.8m) | ($13.7m) | ($19.1m) | ($12.1m) | — | |
| Basic Earnings (Loss) Per Share | — | ($1.41) | ($1.55) | ($2.00) | ($1.50) | ($0.90) | ($0.53) | ($0.57) | ($0.52) | ($0.19) | ($0.84) | |
| Diluted Earnings (Loss) Per Share | — | ($1.41) | ($1.55) | ($2.00) | ($1.50) | ($0.90) | ($0.53) | ($0.57) | ($0.52) | ($0.19) | ($0.84) | |
| Additional Financial Items | ||||||||||||
| Administrative Expense | — | — | $1.4m | $805k | $670k | — | — | $1.0m | $1.0m | $520k | — | |
| Depreciation Right of Use Assets | — | — | — | — | $86k | $57k | $36k | $64k | $112k | $111k | $140k | |
| Employee Benefits Expense | — | — | $910k | $736k | $618k | $1.6m | $706k | $2.7m | $2.5m | $2.4m | — | |
| Expense From Share-Based Payment Transactions With Employees | — | — | — | — | — | — | $1.5m | $984k | $882k | $980k | — | |
| Expense Relating To Leases Of Low-Value Assets For Which Recognition Exemption Has Been Used | — | — | — | — | — | $87k | $79k | $69k | — | — | — | |
| Expense Relating To Short-Term Leases For Which Recognition Exemption Has Been Used | — | — | — | — | $47k | — | — | — | — | — | — | |
| Expense Relating To Variable Lease Payments Not Included In Measurement Of Lease Liabilities | — | — | — | — | $26k | — | — | — | — | — | — | |
| Other Employee Expense | — | — | — | — | — | — | — | $926k | $516k | $1.0m | — | |
| Professional Fees Expense | — | — | $1.3m | $1.5m | $742k | — | — | — | $169k | — | — | |
| Profit Loss Attributable To Owners Of Parent | — | — | — | — | — | $15.3m | $12.8m | $13.8m | — | — | — | |
| Profit Loss Before Tax | — | ($7.5m) | ($8.3m) | ($12.3m) | ($13.5m) | ($15.3m) | ($12.8m) | ($13.7m) | ($19.1m) | ($12.1m) | — | |
| Intellectual property expenses | — | ($242k) | ($225k) | ($322k) | ($353k) | ($360k) | ($365k) | ($285k) | ($214k) | ($128k) | — | |
| General and administration expenses | — | ($4.0m) | ($4.3m) | ($4.3m) | ($3.4m) | ($6.9m) | ($5.5m) | ($5.1m) | ($4.8m) | ($5.5m) | — | |
| Other gains / (losses) | — | — | — | — | — | ($297k) | $2.7m | $918k | $261k | ($67k) | — | |
| Forfeited options from reserves | — | — | — | — | $12k | $66k | — | $17k | — | — | — | |
| Loss for the year | — | ($7.5m) | ($8.3m) | ($12.3m) | ($13.5m) | ($15.3m) | ($12.8m) | ($13.8m) | ($19.1m) | ($12.1m) | — | |
| Other comprehensive loss | — | $0 | $0 | $0 | — | — | — | — | — | — | — | |
| Net Foreign Exchange Loss | — | — | $271k | — | — | — | — | — | — | — | — |